|
|
1.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
|
|
2.
|
Comparison of outcome of higher versus lower transvalvular gradients in patients with severe aortic stenosis and low (<40%) left ventricular ejection fraction. MedStar authors:
- Ben-Dor, Itsik
- Goldstein, Steven A
- Hauville, Camille
- Iyasu, Getachew D
- Laynez-Carnicero, Ana
- Lindsay, Joseph
- Maluenda, Gabriel
- Okubagzi, Petros
- Pichard, Augusto D
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
- Xue, Zhenyi
Year: 2012
Citation: - American Journal of Cardiology. 109(7):1031-7, 2012 Apr 1.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Ben-Dor I, Goldstein SA, Hauville C, Iyasu GD, Laynez-Carnicero A, Lindsay J, Maluenda G, Okubagzi P, Pichard AD, Satler LF, Torguson R, Waksman R, Xue Z
|
